Public perception of dermatologists in France: results from a population-based national survey.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 15 10 2018
accepted: 18 02 2019
pubmed: 6 3 2019
medline: 18 2 2020
entrez: 6 3 2019
Statut: ppublish

Résumé

The public perception of dermatologists, highly relevant for implementing strategies to improve dermatological care, has been scarcely investigated in France, in regard to the background where the number of active dermatologists is continuously decreasing. This study sought to investigate the French public's perception of dermatologists, as well as the physician-patient relationship in dermatology area. A sample of 5000 inhabitants (aged ≥15-80 years) of Metropolitan France, seeking medical advice for a skin condition, were invited in July 2018 to fill in a digital structured questionnaire. The sample's gender ratio and geographical distribution proved representative of the French general population. Compared to 33.2% of respondents having consulted a general practitioner (GP), 20.6% had consulted a dermatologist over the past 12 months, the main reasons being a chronic skin condition (37%), surgical intervention (18%) and naevi check-up (15%). When confronted with acute skin problems, survey participants stated their GP was the first healthcare reference (54% of cases). This may be explained by two distinct phenomena: the declining demography of dermatologists and specific peculiarities of the French healthcare system. Contrarily, the dermatologist was the first care provider for chronic skin problems (47% of cases). On answering the question whether they were satisfied with their last dermatological consultation, 76% declared to be very satisfied/satisfied, vs. 24% dissatisfied/very dissatisfied. Some 78% were given a prescription at consultation end, considered efficacious by 91% and well tolerated by 98%. Our study findings underline the central role of dermatologists in skin care as valued and trusted care providers in France. Further educational and political strategies appear warranted to improve patient referral to dermatologists and decrease waiting times, thereby improving patients' well-being and satisfaction, as well as care quality provided.

Sections du résumé

BACKGROUND BACKGROUND
The public perception of dermatologists, highly relevant for implementing strategies to improve dermatological care, has been scarcely investigated in France, in regard to the background where the number of active dermatologists is continuously decreasing.
OBJECTIVE OBJECTIVE
This study sought to investigate the French public's perception of dermatologists, as well as the physician-patient relationship in dermatology area.
METHODS METHODS
A sample of 5000 inhabitants (aged ≥15-80 years) of Metropolitan France, seeking medical advice for a skin condition, were invited in July 2018 to fill in a digital structured questionnaire.
RESULTS RESULTS
The sample's gender ratio and geographical distribution proved representative of the French general population. Compared to 33.2% of respondents having consulted a general practitioner (GP), 20.6% had consulted a dermatologist over the past 12 months, the main reasons being a chronic skin condition (37%), surgical intervention (18%) and naevi check-up (15%). When confronted with acute skin problems, survey participants stated their GP was the first healthcare reference (54% of cases). This may be explained by two distinct phenomena: the declining demography of dermatologists and specific peculiarities of the French healthcare system. Contrarily, the dermatologist was the first care provider for chronic skin problems (47% of cases). On answering the question whether they were satisfied with their last dermatological consultation, 76% declared to be very satisfied/satisfied, vs. 24% dissatisfied/very dissatisfied. Some 78% were given a prescription at consultation end, considered efficacious by 91% and well tolerated by 98%.
CONCLUSION CONCLUSIONS
Our study findings underline the central role of dermatologists in skin care as valued and trusted care providers in France. Further educational and political strategies appear warranted to improve patient referral to dermatologists and decrease waiting times, thereby improving patients' well-being and satisfaction, as well as care quality provided.

Identifiants

pubmed: 30835850
doi: 10.1111/jdv.15541
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1615

Subventions

Organisme : Abbvie
Organisme : GSK
Organisme : Janssen
Organisme : Sanofi Genzyme
Organisme : Pfizer
Organisme : Pierre Fabre Dermo-Cosmetique
Organisme : Galderma
Organisme : Expanscience
Organisme : Bioderma
Organisme : Bailleul
Organisme : Leo Pharma
Organisme : Société Française de Dermatologie et de Pathologie Sexuellement Transmissible
Organisme : Lilly
Organisme : Novartis
Organisme : La Roche-Posay

Informations de copyright

© 2019 European Academy of Dermatology and Venereology.

Auteurs

M-A Richard (MA)

Dermatology Department, EA 3279: CEReSS -Health Service Research and Quality of Life Center, Assistance Publique Hôpitaux de Marseille, Timone Hospital, Aix-Marseille University, Marseille, France.
Department of Dermatology, CHU la Timone, Marseille, France.
Société Française de Dermatologie (SFD), Paris, France.
Collège des Enseignants de Dermatologie de France (CEDEF), Paris, France.

P Joly (P)

Société Française de Dermatologie (SFD), Paris, France.
Collège des Enseignants de Dermatologie de France (CEDEF), Paris, France.
Dermatological Clinic, Hôpital Charles-Nicolle, Rouen, France.

B Roy Geffroy (B)

Société Française de Dermatologie (SFD), Paris, France.

C Taïeb (C)

Société Française de Dermatologie (SFD), Paris, France.
Public Health, APHP, Hôpital Necker Enfants-Malades, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH